Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BBy
AddedFeb 17, 2024
UpdatedJul 7, 2026
BBy

BBy

Seed

BBy transforms breast milk into lasting, active powder, optimizing NICU care.

HQ
New York City, NY, US
Founded
2017
Accelerator
Y Combinator logoY CombinatorW22
Overview
Compare
Fundraising
Employees
Website

BBy's condensing device turns milk into a fine powder that spares the biome leaving it biologically and immunologically active. This allows hospitals to stop wasting precious nursing time defrosting milk for hours and milk wastage from discarding rules. Simply weigh the powder, add water, shake and serve. No more freezing, no more defrosting, only patient care. NICUs are time sensitive wards in the hospital, time is everything and yet nurses today continue to prepare frozen milk for infants in what's known as the milk shift. A shift where the nurse spends the day defrosting milk for the next shift of nurses.

Our tech is now fully peer reviewed and published, yielding safe and reliable results in over 20 hospitals in the New York Tri-State. The company is headed by Vansh Langer MD, a physician (Windsor University, University of Chicago) and Blanca Aguilar Uscanga PhD, a Bioengineering/Food Science PhD (University of Guadalajara /Centro Universitario de Ciencias Exactas e IngenierĂ­as (CUCEI)) team that has over 50 published works in the field between them and are experts in the science of infant nutrition. Vansh saw the immense need for a time critical solution in the NICU and helped solve the puzzle with Dra. Blanca and her team and decided to work together to: Nurture the Future.

BBy - Similar Companies

Biomilq logo

Biomilq

biomilq.com

Lactation Innovations logo

Lactation Innovations

Harmony Baby Nutrition logo

Harmony Baby Nutrition

Group B Labs logo

Group B Labs

bubbebottle.com

ByHeart logo

ByHeart

byheart.com

Babba logo

Babba

babbacare.com

Lactation Lab logo

Lactation Lab

lactationlab.com

Prolacta Bioscience logo

Prolacta Bioscience

prolacta.com

Milk Stork logo

Milk Stork

milkstork.com

Helaina logo

Helaina

myhelaina.com

Thrive Feeding logo

Thrive Feeding

Bobbie logo

Bobbie

hibobbie.com

Babyation logo

Babyation

babyation.com

Emulait logo

Emulait

emulait.com

Proxamama logo

Proxamama

proxamama.com

BBy - Quick Facts

Who are BBy's competitors?

Companies similar to BBy include Biomilq, Lactation Innovations, Harmony Baby Nutrition and Group B Labs.

When was BBy founded?

BBy was founded in 2017.

Where is BBy's headquarters located?

BBy's headquarters is located in New York City, NY, US.

When was BBy's last funding round?

BBy's most recent funding round was for $3M (USD) in May 2023.

How much has BBy raised to-date?

As of May 25, 2023, BBy has raised a total of $3.6M (USD).

How many employees does BBy have?

BBy has 4 employees as of Feb 4, 2024.

BBy - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Software
Customer
  • Enterprise
Main Product
  • Breast Milk
  • Powder
Tags
  • Healthtech